Who owns Matinas Biopharma Holdings, In?
- Ticker: MTNB
- CUSIP Number: 576810105
Tip: Access positions for across all investors
Analyze quarterly positions in Matinas Biopharma Holdings, In with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Matinas Biopharma Holdings, In stock
Who bought or sold Matinas Biopharma Holdings, In this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 9.3M | $2.5M | 0% | Mar 2024 |
|
| Sargent Investment Group | 3.6M | $978k | -5% | Mar 2024 |
|
| BlackRock | 2.5M | $673k | -1% | Mar 2024 |
|
| Geode Capital Management | 2.1M | $579k | 9% | Mar 2024 |
|
| Arkadios Wealth Advisors | 1.6M | $440k | 0% | Mar 2024 |
|
| Neville Rodie & Shaw | 1.2M | $314k | 0% | Mar 2024 |
|
| JTC Employer Solutions Trustee | 775k | $222k | 0% | Mar 2024 |
|
| LPL Financial | 612k | $166k | -1% | Mar 2024 |
|
| Northern Trust | 431k | $117k | 19% | Mar 2024 |
|
| Main Street Financial Solutions | 401k | $109k | 0% | Mar 2024 |
|
| Staley Capital Advisers | 400k | $108k | 0% | Mar 2024 |
|
| Private Advisor | 347k | $94k | 3% | Mar 2024 |
|
| Virtu Financial | 163k | $35k | 100% | Dec 2023 |
|
| Bank of America Corporation | 130k | $35k | 47644% | Mar 2024 |
|
| Wealth Enhancement Advisory Services | 119k | $32k | 0% | Mar 2024 |
|
| Wells Fargo & Company | 107k | $29k | -54% | Mar 2024 |
|
| Modera Wealth Management | 95k | $26k | 0% | Mar 2024 |
|
| Hyman Charles D | 80k | $22k | 0% | Mar 2024 |
|
| Simplicity Wealth | 60k | $16k | 100% | Mar 2024 |
|
| Bleakley Financial Group | 60k | $16k | 0% | Mar 2024 |
|
| Sawtooth Asset Management | 60k | $13k | 0% | Dec 2023 |
|
| Commonwealth Equity Services | 49k | $13k | -2% | Mar 2024 |
|
| Morgan Stanley | 48k | $13k | 58% | Mar 2024 |
|
| Jpmorgan Chase & Co | 46k | $12k | 0% | Mar 2024 |
|
| UBS Group | 45k | $12k | 100% | Mar 2024 |
|
| National Wealth Management Group | 42k | $11k | 0% | Mar 2024 |
|
| Tower Research Capital | 29k | $7.9k | -38% | Mar 2024 |
|
| Dynamic Advisors Solutions | 28k | $7.5k | 0% | Mar 2024 |
|
| Bridgeway Capital Management | 27k | $7.2k | -73% | Mar 2024 |
|
| Bank of New York Mellon | 20k | $5.5k | -78% | Mar 2024 |
|
| Rossmore Private Capital | 18k | $4.7k | 0% | Mar 2024 |
|
| Clarus Group | 12k | $3.3k | 0% | Mar 2024 |
|
| J.w. Cole Advisors | 11k | $2.9k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 10k | $0 | 44% | Mar 2024 |
|
| CRA Financial Services | 10k | $2.7k | 0% | Mar 2024 |
|
| Advisor Group Holdings | 10k | $2.7k | 0% | Mar 2024 |
|
| FMR | 5.0k | $1.4k | 100% | Mar 2024 |
|
| Steward Partners Investment Advisory | 3.0k | $824.144000 | 0% | Mar 2024 |
|
| EverSource Wealth Advisors | 3.0k | $648.900000 | 0% | Mar 2024 |
|
| IFP Advisors | 643.00 | $139.016600 | 0% | Dec 2023 |
|
Who sold out of Matinas Biopharma Holdings, In?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Connective Capital Management | Dec 2023 | 318k | $69k |
| XTX Topco | Sep 2023 | 34k | $4.4k |
| Two Sigma Securities | Dec 2023 | 19k | $4.1k |
| Bayesian Capital Management | Dec 2023 | 19k | $4.1k |
| Cooper Financial Group | Dec 2023 | 14k | $3.0k |
| Magnus Financial Group | Sep 2023 | 10k | $1.3k |
| Hartford Financial Management | Dec 2023 | 2.5k | $541.000000 |
| Advisory Services Network | Dec 2023 | 2.0k | $432.000000 |
| Global Wealth Management Investment Advisory | Dec 2023 | 650.00 | $140.985000 |